Cargando…

Enthesopathy, Osteoarthritis, and Mobility in X-linked Hypophosphatemia

Detalles Bibliográficos
Autor principal:	Imel, Erik A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Invited Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271761/ https://www.ncbi.nlm.nih.gov/pubmed/32374835 http://dx.doi.org/10.1210/clinem/dgaa242

Ejemplares similares

Development of Enthesopathies and Joint Structural Damage in a Murine Model of X-Linked Hypophosphatemia
por: Faraji-Bellée, Carole-Anne, et al.
Publicado: (2020)

Impaired 1,25-dihydroxyvitamin D(3) action underlies enthesopathy development in the Hyp mouse model of X-linked hypophosphatemia
por: Rana, Rakshya, et al.
Publicado: (2023)

SUN-526 Prevalence of Hyperparathyroidism in X-Linked Hypophosphatemia
por: DeLacey, Sean, et al.
Publicado: (2019)

Long-term Burosumab Administration Is Safe and Effective in Adults With X-linked Hypophosphatemia
por: Weber, Thomas J, et al.
Publicado: (2022)

Musculoskeletal Features in Adults With X-linked Hypophosphatemia: An Analysis of Clinical Trial and Survey Data
por: Javaid, Muhammad Kassim, et al.
Publicado: (2021)

X-Linked Hypophosphatemic Rickets Manifesting as Sclerotic Bone Disease and Enthesopathy
por: Boro, Hiya, et al.
Publicado: (2020)

The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey
por: Skrinar, Alison, et al.
Publicado: (2019)

FGF23, Hypophosphatemia, and Emerging Treatments
por: Imel, Erik A, et al.
Publicado: (2019)

SUN-356 Burosumab Resulted in Greater Clinical Improvements Compared with Higher-dose Conventional Therapy in Children with X-linked Hypophosphatemia (XLH)
por: Imel, Erik A, et al.
Publicado: (2020)

Osteoarthritis, Osteophytes, and Enthesophytes Affect Biomechanical Function in Adults With X-linked Hypophosphatemia
por: Steele, Amy, et al.
Publicado: (2020)

Health Care Transition From Pediatric- to Adult-Focused Care in X-linked Hypophosphatemia: Expert Consensus
por: Dahir, Kathryn, et al.
Publicado: (2021)

Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia
por: Linglart, Agnès, et al.
Publicado: (2021)

Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia
por: Ward, Leanne M, et al.
Publicado: (2022)

Growth Curves for Children with X-linked Hypophosphatemia
por: Mao, Meng, et al.
Publicado: (2020)

Dental management of patients with X-linked hypophosphatemia
por: Lee, Bin-Na, et al.
Publicado: (2017)

Genotype and Phenotype Analysis in X-Linked Hypophosphatemia
por: Park, Peong Gang, et al.
Publicado: (2021)

Impact of X-Linked Hypophosphatemia on Muscle Symptoms
por: Romagnoli, Cecilia, et al.
Publicado: (2022)

Enthesopathies and enthesitis. Part 1. Etiopathogenesis
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2015)

OR13-2 Characterizing the Impact of Burosumab on Bone Health in Children with X-Linked Hypophosphatemia: Results from Year 1 of the Disease Monitoring Program
por: Carpenter, Thomas, et al.
Publicado: (2022)

OR13-2 Burosumab Resulted in Greater Improvement in Rickets Than Conventional Therapy in Children with X-Linked Hypophosphatemia (XLH)
por: Imel, Erik, et al.
Publicado: (2019)

X-Linked Hypophosphatemia: A New Era in Management
por: Dahir, Kathryn, et al.
Publicado: (2020)

X-linked Hypophosphatemia (XLH) Mimicking Rheumatic Disease
por: Takase, Ryosuke, et al.
Publicado: (2020)

Autism and X-linked hypophosphatemia: A possible association?
por: Joël, Vermeersch, et al.
Publicado: (2010)

Burosumab and Dental Abscesses in Children With X‐Linked Hypophosphatemia
por: Gadion, Margaux, et al.
Publicado: (2022)

Craniosynostosis in Patients With X‐Linked Hypophosphatemia: A Review
por: Munns, Craig F, et al.
Publicado: (2023)

Novel PHEX gene locus‐specific database: Comprehensive characterization of vast number of variants associated with X‐linked hypophosphatemia (XLH)
por: Sarafrazi, Soodabeh, et al.
Publicado: (2021)

Serum Levels of Lipocalin Are Lower in Adolescents With X-Linked Hypophosphatemia
por: Simpson, Christine A, et al.
Publicado: (2021)

Enthesopathies and enthesitis. Part 2: Imaging studies
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2015)

Ultrasonographic Enthesopathy and Disease Activity in Psoriatic Arthritis
por: Ahmed, Mohieldin M., et al.
Publicado: (2017)

Health-related quality of life of X-linked hypophosphatemia in Spain
por: Yanes, M. I. Luis, et al.
Publicado: (2022)

Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia
por: Ruppe, Mary D., et al.
Publicado: (2016)

Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose Level
por: Imel, Erik A, et al.
Publicado: (2023)

Increased prevalence of overweight and obesity in children with X-linked hypophosphatemia
por: Zhukouskaya, Volha V, et al.
Publicado: (2020)

Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish population
por: Rodríguez-Rubio, Enrique, et al.
Publicado: (2021)

Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium
por: Laurent, Michaël R., et al.
Publicado: (2021)

Erratum to: “X-Linked Hypophosphatemia: A New Era in Management”
Publicado: (2021)

Ossification of the Posterior Longitudinal Ligament Caused by X-linked Hypophosphatemia
por: Yamamoto, Koichiro, et al.
Publicado: (2023)

Burosumab in X-linked hypophosphatemia: a profile of its use in the USA
por: Lyseng-Williamson, Katherine A.
Publicado: (2018)

Circulating Levels of Leptin and Lipocalin-2 in Patients With X-Linked Hypophosphatemia
por: Simpson, Christine A, et al.
Publicado: (2023)

Imaging the Enthesopathy and Manipulating the Fascia: Ultrasound is the “Sous Chef”
por: Pirri, Carmelo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9i7jd8q29tb4jgl32jtcidkjh3